Clinical Trials Sponsored by Fondation Benoit

Total 17818 results

University of Liege
Fondation Benoit

Unknown

Beneficial Effects of Self-hypnosis/Self-care for Chronic Pain Patients : a MRI and EEG Study

Chronic Pain

Belgium
University of Liege
Fondation Benoit

Withdrawn

Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients

Non-Metastatic Neoplasm

Belgium
Beloit College

Completed

WILD 5 Wellness, A 30-Day Intervention

Depression | Anxiety | Wellness | Cognitive Functioning

United States
Beloit College

Terminated

WILD 5 Wellness: A 30-Day Intervention

Depression | Anxiety | Wellness | Cognitive and Executive Dysfunction

United States
Beloit College

Completed

WILD 5 Wellness: A 30-Day Intervention

Healthy

United States
Benoit Guery

Recruiting

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence (FENDER)

Clostridioides Difficile Infection

Switzerland
Genfit

Completed

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Renal Impairment | Kidney Disease | Renal Disease

United States
Genfit

Terminated

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) (RESOLVE-IT)

Nonalcoholic Steatohepatitis (NASH) With Fibrosis

United States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
Genfit

Terminated

Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)

Non-Alcoholic Fatty Liver

Netherlands
Genfit

Completed

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Kidney Diseases | Renal Insufficiency | Renal Impairment | Pharmacokinetics

France, Romania
Genfit

Completed

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cholangitis (PBC)

United States, United Kingdom, France, Germany, Spain
Genfit

Completed

Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

Bosnia and Herzegovina, Latvia, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Serbia
Genfit

Recruiting

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutation Cholangiocarcinoma

Cholangiocarcinoma

United States, Puerto Rico
Genfit

Completed

Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Insulin Resistance | Abdominal Obesity

France
Genfit

Completed

Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.

Impaired Glucose Tolerance | Abdominal Obesity

France
Genfit

Completed

Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients

Liver Diseases | Moderate Hepatic Impairment | Severe Hepatic Impairment

United States
Genfit

Terminated

Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)

Non Alcoholic Steatohepatitis

United States
Genfit

Completed

Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers

Healthy | Geriatrics

France
Genfit

Completed

Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin

Drug-drug Interaction

France
Genfit

Completed

Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity

Abdominal Obesity | Atherogenic Dyslipidaemia

France, Romania, Tunisia
Britney Benoit
Dalhousie University; IWK Health Centre

Completed

The Influence of Breastfeeding on Cortical Activity During Procedures (iCAP)

Pain | Neonatal

Canada
Ronald M. Benoit, MD

Withdrawn

Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer

Prostate Cancer

United States
University Hospital, Clermont-Ferrand
M2iSH laboratory; Benoit Chassaing

Unknown

Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma. (METABIOTE)

Colorectal Neoplasms | Metabolic Syndrome | Sarcopenia | Microbiota | Prognosis

France
Versantis AG

Recruiting

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)™

Acute-On-Chronic Liver Failure | Ascites

Germany, Spain, Belgium, United States, France
Benobio Co., Ltd.

Not yet recruiting

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

Australia
Heart Care Foundation
Fondazione SISA

Completed

Prevalence of Familial Hypercholesterolaemia (FH) in Italian Patients With Coronary Artery Disease (POSTER)

Coronary Artery Disease

Italy
Uppsala University
The Swedish Society of Medicine; Bengt Ihre Foundation

Completed

Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades (LNMMA)

Gastrointestinal Motility Disorder | Disturbance of Salivary Secretion

Sweden
Bengt Nellgard
Svenska alzheimerfonden; Stroke Foundation

Completed

Biomarkers and Outcome 1 and 10-15 Years After Severe Traumatic Brain Injury

Biomarkers | Brain Injury Traumatic Severe (Diagnosis)

Sweden
University of Benin

Completed

Risk Perception of Periodontal Disease (RPPD)

Periodontal Diseases

Nigeria
University of Benin

Completed

Best Partograph Action Line to Prevent Prolonged Labour (Partograph)

Prolonged First Stage Labor - Prevention
University of Benin

Unknown

Aqueous Mushroom Extract and Intraocular Pressure (AME)

Glaucoma

Nigeria
Uppsala University
The Swedish Society of Medicine; Medtronics, Inc.; Bengt Ihre Foundation

Completed

Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome

Pain | Irritable Bowel Syndrome | Constipation | Diarrhea

Sweden
Haugaard, Steen Bendix, M.D., DMSc

Completed

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes (AddHope2)

Coronary Artery Disease | Diabetes Mellitus, Type 2

Denmark
Genfit
Naturalpha; SGS Aster S.A.S.

Completed

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Cardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | Obese

France
Danone Nutricia SpA Società Benefit

Recruiting

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Autism Spectrum Disorder | Drug Resistant Epilepsy | Chronic Migraine | Brain Tumor, Pediatric

Italy
Heart Care Foundation
Fondazione dell'Associazione Medici Diabetologi

Completed

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry (DYDA2)

Diabetes Mellitus, Type 2 | Left Ventricular Systolic Dysfunction

Italy
University of Benin
UBTH

Completed

IMPACT OF PAMPHLET ON THE KNOWLEDGE OF HEALTH EFFECT OF SMOKING

Tobacco Use Cessation

Nigeria
Fondazione per la Ricerca Farmacologica Gianni...
Barau Dikko Teaching Hospital

Completed

A Study Aimed to Assess the Needs of Subjects With Sickle Cell Disease and Healthcare Professionals Managing Sickle Cell Disease Patients in Selected Nigerian Centres

Sickle Cell Disease

Nigeria
University Children's Hospital Basel
Swiss National Science Foundation; Fondation Botnar

Completed

Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis (D2OBREATH)

De Novo Lipogenesis (DNL)

Switzerland
Calmy Alexandra
University Hospital, Geneva; Swiss National Science Foundation; Swiss Heart Foundation and other collaborators

Terminated

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART (NILACH)

Atherosclerosis | HIV

Switzerland
University Hospital, Geneva
Fondation Privée des HUG; IF International Foundation

Not yet recruiting

Evaluation of a New Recovery-oriented Model of Psychiatric Inpatient Care

Recovery | Psychiatric Hospitalization | Coercion

Switzerland
Fondation Ophtalmologique Adolphe de Rothschild
Foundation Jacques and Gloria Gossweiler

Terminated

Finger Individuation Training With a Training Device Versus Conventional Rehabilitation for Writer's Cramp (FIDEX)

Dystonic Disorders

France
Merna Mawgoud Zaki Bechit

Not yet recruiting

Correlation Between H.Pylori Colonization and Gastritis

Gastritis H Pylori
Genfit
Premier Research Group plc; Naturalpha

Completed

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
Genfit
University of Miami; Syneos Health

Completed

Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients

Pharmacokinetics | Hepatic Impairment | Liver Disease

United States
Universidad Autónoma Benito Juárez de Oaxaca

Completed

Evaluating Acupuncture Relationship With the Catecholaminergic Pathway

Low Back Pain
I.R.C.C.S. Fondazione Santa Lucia
Alzheimer's Drug Discovery Foundation

Active, not recruiting

Dopaminergic Therapy for Frontotemporal Dementia Patients

Mental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurologic Manifestations | Neurobehavioral Manifestations | Neurocognitive Disorders | Neurodegenerative Diseases | TDP-43 Proteinopathies | Proteostasis Deficiencies | Dementia | Language Disorders | Communication... and other conditions

Italy
Fundacion Miguel Servet
Hospital Universitario Getafe; Matia Foundation

Unknown

Impact of a Multicomponent Exercise Program on Functional Capacity in Frail Aged Participants With Cognitive Decline

Cognitive Impairment | Frail Elderly Syndrome

Spain
Universidad Autónoma Benito Juárez de Oaxaca

Unknown

Aromatherapy With Lavender Essential Oil as a Complementary Treatment for the Control of Dental Anxiety

Dental Anxiety
Genfit
Eurofins Optimed; PhinC Development; CardiaBase

Completed

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Healthy Volunteers

France

Clinical Trials Sponsored by Fondation Benoit

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations